A company with a unique mission
Urovant Sciences is a biopharmaceutical company dedicated to advancing the quality of care in urology. With a pipeline of investigational therapies and opportunities for product partnerships, Urovant is growing into a leader in this challenging category.
- Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Seasonread moreNov 14, 2022
- Urovant Sciences Announces Publication of Pharmacokinetic Data on GEMTESA® (Vibegron 75mg) Administered as an Intact or Crushed Ta…read moreOct 27, 2022
- Urovant Sciences® Receives “Best in Category” Award for Abstract Highlighting Investigational Novel Gene Therapy, URO-902, Present…read moreSep 08, 2022
Urovant was recognized by life sciences marketing industry trade publication PM360with the Product Launch of the Year Trailblazer award for GEMTESA®
This recognition is based on employees describing their experiences of trust and reaching their full potential, and on the consistency of all employees' feedback regarding innovation, company values, and effectiveness of their leaders.Read more
This is Urovant Science's second year in a row to earn this recognition, reflecting the company's people-focused culture and dedication to improving urologic care for patients around the world.Read more
This certification is the definitive "employer-of-choice" recognition companies aspire to achieve, as it is the only recognition based entirely on employees' feedback about their workplace experience.Read more
This county-wide survey and awards program was designed to identify, recognize, and honor the best places of employment in Orange County, California, benefiting the county’s economy, its workforce, and businesses.Read more
Awarded by the American Urological Association for outstanding support of the AUA and Urology Care Foundation (UCF) programs in research, education, and health equity in urology.